Results 121 to 130 of about 1,141 (182)

Antifungal prophylaxis against invasive Candida and Aspergillus infection in adult heart transplant recipients: protocol for a systematic review and meta-analysis [PDF]

Introduction: Invasive fungal infections (IFI) can contribute to increased mortality and morbidity rates after heart transplant in adults. The most common causes are Aspergillus and Candida species.
Irshad, Zahra, Jenkins, Abi, Lim, Hoong Sern, Maidment, Ian D.   +3 more
core   +1 more source

Update on therapeutic approaches for invasive fungal infections in adults

Therapeutic Advances in Infectious Disease
Invasive fungal infections are increasingly encountered with the expansion of iatrogenic immunosuppression, including not only solid organ and hematopoietic stem cell transplant recipients but also patients with malignancies or autoimmune diseases ...
Catherine-Audrey Boutin, Me-Linh Luong
doaj   +1 more source

Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized Trials. [PDF]

Open Forum Infect Dis
Ostrosky-Zeichner L, Aram JA, Redell M, Thompson GR, Cornely OA, McKinnell JA, Spec A, Pappas PG.   +7 more
europepmc   +1 more source

Rezafungin exhibits anti-biofilm properties against fungal biofilms in vitro. [PDF]

J Antimicrob Chemother
Abduljalil H, Bartie K, Bal AM, Rautemaa-Richardson R, Williams C, Kean R, Ramage G.   +6 more
europepmc   +1 more source

Rezafungin for the treatment of invasive candidiasis secondary to esophagogastric anastomotic leak: clinical success in a complex situation. [PDF]

Rev Esp Quimioter
Estévez A, Lalinde D, Ramos R, Piñeiro P, Muñoz P.   +4 more
europepmc   +1 more source

New preparations in systemic fungal infections [PDF]

Introducere Infecțiile fungice sistemice (invazive) reprezintă o problemă medicală și de sănătate publică majoră în ultimele două decenii. S-a estimat că, la nivel global, 1-1,2 miliarde de persoane sunt afectate de fungi, cu aproximativ 1,5 milioane ...
Bacinschi, Nicolae, Catcov, Carolina, Spînosu, Galina   +2 more
core  

Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern

, 2023
Mishra Baishnab, Shyam Kumar , Mishra, SK, Willcox, M , Yasir, M   +3 more
core   +1 more source

Rezafungin in fluconazole-resistant and refractory candidiasis: the first Brazilian experience. [PDF]

Rev Inst Med Trop Sao Paulo
Kruschewsky WLL, Nakagawa JAS, Siqueira LPM, Taborda M, de Oliveira VF, Abdala E, Magri ASGK, Magri MMC.   +7 more
europepmc   +1 more source

Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessment. [PDF]

JAC Antimicrob Resist
Law SM, Choyce A, Barzinji H, Ellis H, Kosmidis C, Seaton RA.   +5 more
europepmc   +1 more source

Efficacy of Rezafungin on <i>Candida albicans</i> Endophthalmitis in a Rabbit Model. [PDF]

Pathog Immun
Saghir J, Herrada J, Long L, Valentin ES, McCormick TS, Ghannoum M.   +5 more
europepmc   +1 more source